Gastrointestinal Oncology Program
Program Orientation/Overview
The Gastrointestinal (GI) Oncology Program at Moffitt Cancer Center is a specialized, interdisciplinary program that is focused on the treatment and prevention of cancers of the esophagus, stomach, pancreas, bile ducts, gallbladder, small intestine, retroperitoneum, colon, rectum, anus and liver.
Interdisciplinary Treatment Approach
Our interdisciplinary team approach to patient care means that a gastrointestinal patient is seen by a cancer specialist with expertise in gastrointestinal oncology. At a weekly meeting, the patient's case is also reviewed by a gastrointestinal surgeon, a medical oncologist and a radiation oncologist. Diagnostic radiologists, pathologists, oncology nurses, social workers, registered dietitians and other medical professionals round out the team.
Patient-Centered Care
The mission of the GI Tumor Program is to deliver individualized compassionate care to the patient with GI cancer or the person who is at risk to develop GI cancer by personalized interventions. We also provide many support services for both the patient and family to help them cope with the stress that can accompany a serious illness.
Translational Research
For many years only a few select treatments and drugs were available to treat GI tumors. The GI Program physicians and other Moffitt Cancer Center scientists are busy discovering and translating novel drugs to bring the very latest interventions to patients. We are selecting drugs that have the ability to target tumor cells with greater precision than do standard drugs and to prevent cancers with virtually no toxicity. We strongly believe this aggressive approach to finding new treatments will allow us to accomplish our mission to contribute to the prevention and cure of GI cancers.